Thomson Reuters Launches Thomson Pharma KOLexperts(R) to Help the Pharmaceutical Industry Objectively Identify, Verify and Rank Scientific Experts, Product Advocates, Clinical Investigators and Key Opinion Leaders

    PHILADELPHIA and LONDON, Oct. 15 /CNW/ -- Thomson Reuters, the world's
leading source of intelligent information for businesses and professionals,
announced today the launch of Thomson Pharma KOLexperts, a new solution
designed to help pharmaceutical organizations identify, verify, and develop
productive relationships with key opinion leaders (KOLs) and scientific
experts. It is the first solution available to the industry that allows users
to rank life sciences KOLs with a range of objective metrics.  Designed for
scientific expertise identification, Thomson Pharma KOLexperts offers a
variety of tools to find experts with specific scientific competencies.

    "Leveraging external experts is crucial to the success of drug
development today.  Our customers increasingly want to build their research,
clinical and marketing teams based on objective criteria such as scientific
credibility, but lack the information and analysis to do so.  We have
harnessed Thomson Reuter's long legacy in information aggregation, citation
analysis, and scientific expertise to deliver a first-in-class solution to our
customers," said Wendy Hamilton, vice president, product strategy,
Pharmaceutical and Chemicals Markets, Thomson Reuters. "When designing Thomson
Pharma KOLexperts, our objective was to create a life sciences 'Who's Who' of
experts that can be leveraged at any point from discovery to market.  We
utilize trusted data that is skillfully indexed, carefully researched, and
always up to date."

    Users of Thomson Pharma KOLexperts can search for and view experts in a
therapy area of interest, and determine a scientist's ranking at a glance as
extrapolated from cited work, research activity, speaking engagements and
other promotional or educational efforts.  As there is no one ranking system
that addresses all priorities and considerations, the customer can adjust the
ranking approach directly within the product using simple point and click. The
solution brings together the core databases of Thomson Reuters with key
external data sources to offer an up-to-the-minute snapshot of an expert's
status.  It also allows users to identify the scientists recognized as leaders
in their therapeutic areas and highlight new and emerging stars.

    "In the face of an emerging regulatory environment that demands greater
transparency into KOL selection and fair remuneration, objectively identifying
KOLs based on scientific merit paves the way for success throughout the drug
development and marketing process. Thomson Pharma KOLexperts is the first
product to enable the optimal alignment of KOLs with the business strategies
of individual life sciences organizations based on science, not subjectivity,"
added Hamilton.

    Thomson Pharma KOLexperts can be adapted to the unique needs of each
subscribing company. In addition to the standard product, new types of expert
profiles can be created upon demand based on customer request.

    For more information, visit:

    About Thomson Reuters
    Thomson Reuters is the world's leading source of intelligent information
for businesses and professionals.  We combine industry expertise with
innovative technology to deliver critical information to leading decision
makers in the financial, legal, tax and accounting, scientific, healthcare and
media markets, powered by the world's most trusted news organization. With
headquarters in New York and major operations in London and Eagan, Minnesota,
Thomson Reuters employs more than 50,000 people in 93 countries. For more
information, go to


For further information:

For further information: Eoin Bedford, Scientific, +44(0)2074334691,

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890